| Aktie | Ticker | 2025/Q4 | 2025/Q3 | ||||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 875.203.990 $ | +234.748.159 $ | +19,0 % | 665.990.532 $ | +665.990.532 $ | |||
| BANK OF AMERICA CORP /DE/ | BAC | 726.408.630 $ | +241.333.254 $ | +49,8 % | 485.075.376 $ | +485.075.376 $ | |
| INSMED Inc | INSM | 45.997.554 $ | -52.956 $ | -0,1 % | 46.050.510 $ | +46.050.510 $ | |
| UNITED THERAPEUTICS Corp | UTHR | 30.979.355 $ | -4.786.804 $ | -13,4 % | 35.766.159 $ | +35.766.159 $ | |
| Ascendis Pharma A/S | ASND | 28.106.738 $ | -977.376 $ | -3,4 % | 29.084.114 $ | +29.084.114 $ | |
| ARGENX SE | ARGX | 19.557.133 $ | -9.035.856 $ | -31,6 % | 28.592.989 $ | +28.592.989 $ | |
| NEUROCRINE BIOSCIENCES INC | NBIX | 25.534.701 $ | +25.534.701 $ | ||||
| CYTOKINETICS INC | CYTK | 20.692.945 $ | +6.689.412 $ | +47,8 % | 14.003.533 $ | +14.003.533 $ | |
| MoonLake Immunotherapeutics | MLTX | 3.461.635 $ | +1.578.485 $ | +83,8 % | 1.883.150 $ | +1.883.150 $ | |
| 875.203.990 $ | +234.748.159 $ | +19,0 % | 665.990.532 $ | +665.990.532 $ | |||